InvestorsHub Logo
Followers 0
Posts 1472
Boards Moderated 0
Alias Born 01/01/2004

Re: altarboy4 post# 23594

Wednesday, 04/06/2005 7:07:15 PM

Wednesday, April 06, 2005 7:07:15 PM

Post# of 82595
altar..........................

Selective vision by doug and matt and the immaturity of many posters herein have promoted my increasing presence. Enjoy.

The accompanying consolidated financial statements of DNAPrint genomics, Inc.
and Subsidiary have been prepared assuming that the Company will continue as a
going concern. As more fully described in Note B, the Company has had recurring
operating losses since inception, has negative working capital as of December
31, 2004, and has used approximately $3,764,000 of cash in operations for the
year ended December 31, 2004. These conditions raise substantial doubt about the
Company's ability to continue as a going concern. Management's plans regarding
these matters are also described in Note B. The consolidated financial
statements do not include any adjustments that might result from the outcome of
this uncertainty.

http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=3370094

There comes a time when you define the moment, or the moment defines you. - Tin Cup